Search
for
Sort by
Research 91–120 of 1000+
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Definition criteria and diagnostic assessments
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- Hair physiology and its disorders
- Keratin disorders: from gene to therapy
- Biology of Human Hair: Know Your Hair to Control It
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice
- Obesity and the skin
- Alopecia Areata
- Pathophysiology of the burn scar
- Polycystic ovary syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The Role of Methylacrylylated Hyaluronic Acid Hydrogels in Promoting Skin Wound Healing
- Health and fertility in World Health Organization group 2 anovulatory women
- Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Diagnostic approach to low‐renin hypertension
- Syndromes of Severe Insulin Resistance (SSIRs)
- Polycystic ovary syndrome and impact on health
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Chapter 14 Principles of drug metabolism
- Alopecia areata update
- Cutaneous reactions to recombinant cytokine therapy
- Current management strategies for cutaneous T-cell lymphoma
- Teriflunomide in multiple sclerosis: an update
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Immunomodulators in the treatment of cutaneous lymphoma
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review